Back to Journals » Breast Cancer: Targets and Therapy » Volume 7

BP-C1 in the treatment of patients with stage IV breast cancer: a randomized, double-blind, placebo-controlled multicenter study and an additional open-label treatment phase [Corrigendum]

Authors Larsen S, Butthongkomvong K, Manikhas A, Lindkær-Jensen S, Trishkina E, Poddubudkaya E, Matrosova M, Srimuninnimit V

Received 18 March 2015

Accepted for publication 18 March 2015

Published 29 June 2015 Volume 2015:7 Pages 163—164

DOI https://doi.org/10.2147/BCTT.S84920


Larsen S, Butthongkomvog K, Manikhas A, et al. Breast Cancer: Targets and Therapy. 2014;6:179–189.

On page 184 there is an error in Figure 3A. The error consists of a yellow bar at +16 days in the placebo group.

Read the original article

Creative Commons License This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution - Non Commercial (unported, v3.0) License. By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms.

Download Article [PDF]  View Full Text [HTML][Machine readable]